NCT04361006View on ClinicalTrials.gov

Cryotherapy Versus Radiofrequency Ablation for Treatment of Para-hisian Accessory Pathways

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 1, 2018

Primary Completion Date

February 28, 2020

Study Completion Date

February 1, 2021

Conditions
Cardiac ArrhythmiasAccessory PathwayWolf Parkinson White Syndrome
Interventions
DEVICE

Radiofrequency (RF)

Will be evaluated if percutaneous radiofrequency catheter ablation is superior to cryotherapy as treatment modality of para-hisian accessory pathways.

DEVICE

Cryotherapy (CRYO)

Will be evaluated if percutaneous cryotherapy catheter ablation is superior to radiofrequency as treatment modality of para-hisian accessory pathways.

Trial Locations (1)

05403010

Arrhythmia Clinical Unit - Instituto do Coração - HCFMUSP, São Paulo

All Listed Sponsors
collaborator

InCor Heart Institute

OTHER

lead

University of Sao Paulo General Hospital

OTHER

NCT04361006 - Cryotherapy Versus Radiofrequency Ablation for Treatment of Para-hisian Accessory Pathways | Biotech Hunter | Biotech Hunter